These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30418678)

  • 1. Evaluation of the impact of a clinical pathway on the progression of acute urinary retention.
    Gas J; Liaigre-Ramos A; Caubet-Kamar N; Beauval JB; Lesourd M; Prudhomme T; Huyghe E; Soulié M; Charpentier S; Gamé X
    Neurourol Urodyn; 2019 Jan; 38(1):387-392. PubMed ID: 30418678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Reten-World survey of the management of acute urinary retention: preliminary results.
    Emberton M; Fitzpatrick JM
    BJU Int; 2008 Mar; 101 Suppl 3():27-32. PubMed ID: 18307683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.
    Desgrandchamps F; De La Taille A; Doublet JD;
    BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia.
    Fitzpatrick JM; Desgrandchamps F; Adjali K; Gomez Guerra L; Hong SJ; El Khalid S; Ratana-Olarn K;
    BJU Int; 2012 Jan; 109(1):88-95. PubMed ID: 22117624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha blockers prior to removal of a catheter for acute urinary retention in adult men.
    Zeif HJ; Subramonian K
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006744. PubMed ID: 19821385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of successful trial without catheter following acute urinary retention in benign prostatic enlargement: A single centre, multivariate analysis.
    Bansal A; Arora A
    Neurourol Urodyn; 2017 Sep; 36(7):1757-1762. PubMed ID: 28101889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial on the efficacy of bladder training before removing the indwelling urinary catheter in patients with acute urinary retention associated with benign prostatic hyperplasia.
    Zhengyong Y; Changxiao H; Shibing Y; Caiwen W
    Scand J Urol; 2014 Aug; 48(4):400-4. PubMed ID: 24697345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective pilot study to validate the management protocol for patients presenting with acute urinary retention: a community-based, nonhospitalised protocol.
    Gopi SS; Goodman CM; Robertson A; Byrne DJ
    ScientificWorldJournal; 2006 Jun; 6():2436-41. PubMed ID: 17619714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management outcome of acute urinary retention: model of prediction.
    Daly P; Connolly S; Rogers E; Sweeney P
    Urol Int; 2009; 83(1):39-43. PubMed ID: 19641357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate size influences the outcome after presenting with acute urinary retention.
    McNeill AS; Rizvi S; Byrne DJ
    BJU Int; 2004 Sep; 94(4):559-62. PubMed ID: 15329112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study.
    McNeill SA; Hargreave TB; Roehrborn CG;
    Urology; 2005 Jan; 65(1):83-9; discussion 89-90. PubMed ID: 15667868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and meta-analysis on management of acute urinary retention.
    Yoon PD; Chalasani V; Woo HH
    Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):297-302. PubMed ID: 26195469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of conservatively managed acute urinary retention: prostate size matters.
    Kumar V; Marr C; Bhuvangiri A; Irwin P
    BJU Int; 2000 Nov; 86(7):816-9. PubMed ID: 11069406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia.
    Tiong HY; Tibung MJ; Macalalag M; Li MK; Consigliere D
    Urol Int; 2009; 83(1):44-8. PubMed ID: 19641358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does acute urinary retention respond to alpha-blockers alone?
    McNeill SA
    Eur Urol; 2001 Mar; 39 Suppl 6():7-12. PubMed ID: 11306895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention.
    McNeill SA; Hargreave TB;
    J Urol; 2004 Jun; 171(6 Pt 1):2316-20. PubMed ID: 15126812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency management of acute urinary retention: results from an all-Ireland urologist practice survey.
    Cullen IM; Dowling CM; Thornhill JA; Grainger R
    Ir J Med Sci; 2013 Jun; 182(2):207-11. PubMed ID: 23096424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obstruction.
    Alan McNeill S
    Eur Urol; 2004 Mar; 45(3):325-32. PubMed ID: 15036678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of management of patients presenting with acute urinary retention due to benign prostatic hyperplasia: a hospital based study.
    Pandit RK; Agrawal CS; Chalise PR; Sapkota G
    Kathmandu Univ Med J (KUMJ); 2008; 6(24):448-52. PubMed ID: 19483424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of treatment with tamsulosin in men with acute urinary retention.
    Kim HL; Kim JC; Benson DA; Bales GT; Gerber GS
    Tech Urol; 2001 Dec; 7(4):256-60. PubMed ID: 11763483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.